• Special Comments
  • Neonatal Intensive Care Drug Manual




    Download 1,5 Mb.
    bet375/654
    Sana03.01.2022
    Hajmi1,5 Mb.
    #14803
    1   ...   371   372   373   374   375   376   377   378   ...   654
    Adverse Reactions

    See Precautions.

    Compatibility

    N/A

    Incompatibility

    N/A

    Stability

    6 months once bottle opened.

    Storage

    Protect from light. Cool dry location (temp < 30°C).

    Store in Dangerous Drug (DD) safe and record use in DD register. Discard any diluted unused potion.



    Special Comments

    Prolonged use (> 5–7 days) may be associated with dependence.

    Evidence summary

    Efficacy:

    Analgesia in opioid-naïve infants: Oral analgesia with morphine for acute or chronic pain has not been systematically evaluated in neonates.

    Recommended analgesic doses of morphine sulfate for use in neonates are 0.05-0.1 mg/kg intravenously [3]. Estimated oral morphine bioavailability 48.5% in neonates [1]. (LOE IV GOR C) This equates to an estimated intermittent oral dose 0.1–0.2 mg/kg. Duration of analgesia 4–5 hours [4].

    Intravenous morphine mean steady-state serum concentration of 15 ng/mL can be achieved in children after non-cardiac surgery in an intensive care unit with a morphine hydrochloride infusion of 7.5 microgram/kg/hour at birth (term neonates), 12.5 microgram/kg/hour at 1 month, 20 microgram/kg/hour at 3 months [5, 6]. [LOE IV] As oral morphine bioavailability in neonates averaged 48.5% [1], initial estimated daily oral morphine dose is 360 microgram/day (term infants); 600 microgram/day (at 1 month); 960 micrograms/day (at 3 months) in 4–6 equally divided doses.


    Download 1,5 Mb.
    1   ...   371   372   373   374   375   376   377   378   ...   654




    Download 1,5 Mb.

    Bosh sahifa
    Aloqalar

        Bosh sahifa



    Neonatal Intensive Care Drug Manual

    Download 1,5 Mb.